BioCentury | Apr 29, 2020
Emerging Company Profile

Bugworks: breaking the U.S.-centric antimicrobial mold

...and V. Balasubramanian University collaborators: St. John’s Research Institute, Narayana Health, Tokyo Institute of Technology, University of Liverpool...
BioCentury | Aug 2, 2019
Company News

Aug. 1 Company Quick Takes: Nektar gains on breakthrough for NKTR-214; plus Adaptive's MRD test, Acadia, Vanda and more

...S.A.S. (Lyon, France), Bioaster, Helmholtz Centre for Infection Research, North Bristol National Health Service Trust, University of Liverpool...
BioCentury | Jan 23, 2019
Distillery Therapeutics

Infectious disease

...email: steve.ward@lstmed.ac.uk CONTACT: Paul M. O’Neill, University of Liverpool, Liverpool, U.K. email: pmoneill@liverpool.ac.uk Sandi Wong Liverpool School of Tropical Medicine University of Liverpool Infectious...
BioCentury | Jan 23, 2019
Translation in Brief

Partners in Neglected Infections

...In a Proceedings of the National Academy of Sciences paper published on Jan. 7, the University of Liverpool...
...awarded in 2014 by Japan's Global Health Innovative Technology Fund (GHIT Fund) to LSTM, the University of Liverpool...
...drugs to treat the parasitic diseases. Sandi Wong, Staff Writer AstraZeneca plc Eisai Co. Ltd. Liverpool School of Tropical Medicine University of Liverpool Infectious...
BioCentury | Jan 8, 2019
Distillery Therapeutics

Infectious disease

...email: Steve.Ward@lstmed.ac.uk CONTACT: Paul M. O’Neill, University of Liverpool, Liverpool, U.K. email: P.M.Oneill01@liverpool.ac.uk Claire Quang Liverpool School of Tropical Medicine University of Liverpool Infectious...
BioCentury | Jun 6, 2018
Distillery Therapeutics

Neurology

...CONTACT: Lucia Banci, University of Florence, Sesto Fiorentino, Italy email: banci@cerm.unifi.it CONTACT: S. Samar Hasnain, University of Liverpool...
BioCentury | May 25, 2018
Company News

conect4children consortium launches to improve pediatric clinical trials

...10 industry members from 20 European countries and is led by Fondazione PENTA Onlus, the University of Liverpool...
...unit of Johnson & Johnson (NYSE:JNJ), and Bayer AG (Xetra:BAYN). Fondazione PENTA Onlus, Padova, Italy University of Liverpool...
...Johnson (NYSE:JNJ), New Brunswick, N.J. Bayer AG (Xetra:BAYN), Leverkusen, Germany Business: Other Mary Romeo Bayer AG Johnson & Johnson University of Liverpool...
BioCentury | May 21, 2018
Clinical News

European consortium launches to improve pediatric trials

...10 industry members from 20 European countries and is led by Fondazione PENTA Onlus, the University of Liverpool...
...Pharmaceutica NV unit of Johnson & Johnson (NYSE:JNJ), and Bayer AG (Xetra:BAYN). Mary Romeo Bayer AG Janssen Johnson & Johnson University of Liverpool...
BioCentury | Nov 2, 2017
Targets & Mechanisms

Golden State of DUBs

...Forma Asset Discovery and Development Company subsidiaries, and a group of principal investigators from the University of Liverpool...
...Netherlands Progenra Inc., Malvern, Pa. Roche (SIX:ROG; OTCQX:RHHBY), Basel, Switzerland University of Connecticut, Storrs, Conn. University of Liverpool...
BioCentury | Jul 21, 2016
Emerging Company Profile

Drugging the undruggable

...Chris Torrance and Ashok Venkitaraman University collaborators: The Babraham Institute , University of Cambridge , University of Liverpool...
Items per page:
1 - 10 of 36
BioCentury | Apr 29, 2020
Emerging Company Profile

Bugworks: breaking the U.S.-centric antimicrobial mold

...and V. Balasubramanian University collaborators: St. John’s Research Institute, Narayana Health, Tokyo Institute of Technology, University of Liverpool...
BioCentury | Aug 2, 2019
Company News

Aug. 1 Company Quick Takes: Nektar gains on breakthrough for NKTR-214; plus Adaptive's MRD test, Acadia, Vanda and more

...S.A.S. (Lyon, France), Bioaster, Helmholtz Centre for Infection Research, North Bristol National Health Service Trust, University of Liverpool...
BioCentury | Jan 23, 2019
Distillery Therapeutics

Infectious disease

...email: steve.ward@lstmed.ac.uk CONTACT: Paul M. O’Neill, University of Liverpool, Liverpool, U.K. email: pmoneill@liverpool.ac.uk Sandi Wong Liverpool School of Tropical Medicine University of Liverpool Infectious...
BioCentury | Jan 23, 2019
Translation in Brief

Partners in Neglected Infections

...In a Proceedings of the National Academy of Sciences paper published on Jan. 7, the University of Liverpool...
...awarded in 2014 by Japan's Global Health Innovative Technology Fund (GHIT Fund) to LSTM, the University of Liverpool...
...drugs to treat the parasitic diseases. Sandi Wong, Staff Writer AstraZeneca plc Eisai Co. Ltd. Liverpool School of Tropical Medicine University of Liverpool Infectious...
BioCentury | Jan 8, 2019
Distillery Therapeutics

Infectious disease

...email: Steve.Ward@lstmed.ac.uk CONTACT: Paul M. O’Neill, University of Liverpool, Liverpool, U.K. email: P.M.Oneill01@liverpool.ac.uk Claire Quang Liverpool School of Tropical Medicine University of Liverpool Infectious...
BioCentury | Jun 6, 2018
Distillery Therapeutics

Neurology

...CONTACT: Lucia Banci, University of Florence, Sesto Fiorentino, Italy email: banci@cerm.unifi.it CONTACT: S. Samar Hasnain, University of Liverpool...
BioCentury | May 25, 2018
Company News

conect4children consortium launches to improve pediatric clinical trials

...10 industry members from 20 European countries and is led by Fondazione PENTA Onlus, the University of Liverpool...
...unit of Johnson & Johnson (NYSE:JNJ), and Bayer AG (Xetra:BAYN). Fondazione PENTA Onlus, Padova, Italy University of Liverpool...
...Johnson (NYSE:JNJ), New Brunswick, N.J. Bayer AG (Xetra:BAYN), Leverkusen, Germany Business: Other Mary Romeo Bayer AG Johnson & Johnson University of Liverpool...
BioCentury | May 21, 2018
Clinical News

European consortium launches to improve pediatric trials

...10 industry members from 20 European countries and is led by Fondazione PENTA Onlus, the University of Liverpool...
...Pharmaceutica NV unit of Johnson & Johnson (NYSE:JNJ), and Bayer AG (Xetra:BAYN). Mary Romeo Bayer AG Janssen Johnson & Johnson University of Liverpool...
BioCentury | Nov 2, 2017
Targets & Mechanisms

Golden State of DUBs

...Forma Asset Discovery and Development Company subsidiaries, and a group of principal investigators from the University of Liverpool...
...Netherlands Progenra Inc., Malvern, Pa. Roche (SIX:ROG; OTCQX:RHHBY), Basel, Switzerland University of Connecticut, Storrs, Conn. University of Liverpool...
BioCentury | Jul 21, 2016
Emerging Company Profile

Drugging the undruggable

...Chris Torrance and Ashok Venkitaraman University collaborators: The Babraham Institute , University of Cambridge , University of Liverpool...
Items per page:
1 - 10 of 36